Search - tctmd.com

Displaying 21 - 40 of 79

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

Presentation TCT 2023

Pro vs. Con, Asymptomatic Carotid Disease: Revascularization Is Indicated – But When, Why, and How?

Presenter: Lawrence Garcia

October 26, 2023

Presentation TCT 2023

Pro vs Con, Asymptomatic Carotid Disease: Medical Management Is Standard of Care

Presenter: Christopher Metzger

October 26, 2023

Presentation TCT 2023

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

Presenter: APURVA BHARUCHA

October 26, 2023

Presentation TCT 2023

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Omar Abdelfattah

October 26, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Presentation TCT 2022

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

Presenter: Tom Cahill

September 18, 2022

Presentation TCT 2021

Rationale of Earlier AS Treatment: Asymptomatic Severe AS and Moderate AS

Presenter: Nicolas Van Mieghem

November 05, 2021

News Conference News TCT 2021

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

Todd Neale

November 04, 2021

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Presenter: Philippe Genereux

October 16, 2020

Presentation TCT 2019

Case Introduction: Revascularization of Asymptomatic Chronic Total Occlusions

Presenter: Leong Lee, MD

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Presentation TCT 2019

Flash Debate: Carotid Artery Stenting Is Best for the Asymptomatic Patient!

Presenter: Christopher J White

September 28, 2019

Presentation TCT 2019

Utility of Coronary Physiology Assessment in the Asymptomatic Patient

Presenter: Stephane Fournier

September 26, 2019

Presentation TCT 2018

Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

Case #1: Carotid Artery Intervention for Asymptomatic Carotid Artery Stenosis: Why And How

Presenter: Gavin Britz, Aman B. Patel, Matthew Koch, Virendra I Patel, Adnan Siddiqui, Scott Silverman, Jose M. Wiley

September 22, 2018

Presentation TCT 2018

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Presenter: Philippe Genereux

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Presenter: Eric Van Belle

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Presenter: Philippe Pibarot

September 22, 2018

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

Advertisement

What’s Going to Be Big at TCT 2024?

Pro vs. Con, Asymptomatic Carotid Disease: Revascularization Is Indicated – But When, Why, and How?

Pro vs Con, Asymptomatic Carotid Disease: Medical Management Is Standard of Care

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

Rationale of Earlier AS Treatment: Asymptomatic Severe AS and Moderate AS

Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Case Introduction: Revascularization of Asymptomatic Chronic Total Occlusions

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Flash Debate: Carotid Artery Stenting Is Best for the Asymptomatic Patient!

Utility of Coronary Physiology Assessment in the Asymptomatic Patient

Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies

Case #1: Carotid Artery Intervention for Asymptomatic Carotid Artery Stenosis: Why And How

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content